baber/WOPTO huggingface dataset:
Patent NZ-541723-A (NZ)
Title: Tanning booth
Inventor: SMITH WARRICK J
IPC: B05B15/12
Filed: 2004-02-06
Abstract: A booth (2) for accommodating a person, the booth defining a booth volume (4) and comprising: a base portion (6) and a top portion (8); flow means (18) for causing a downward airflow within the booth; projecting means (22) for projecting product into at least some of the booth volume within the booth and, in use, onto a body of a person positioned in the booth; and control means (90) for controlling the projection of the product.
Patent NZ-542578-A (NZ)
Title: System and method for data transmission and reception
Inventor: PEKONEN HARRI
IPC: H04N19/89
Filed: 2003-04-23
Abstract: A method for data transmission comprises placing one or more data segments into a two-dimensional structure (103) having first directional arrangement and second directional arrangement which are perpendicular to each other and placement is with respect to first directional arrangements; adding to each second directional arrangements one or more corresponding computed characteristic values (107), transmitting the contents of one or more first directional arrangements that hold portions of the characteristic values, adding to each of the data segments a data structure placement indication and transmitting the one or more data segments.
Patent NZ-542725-A (NZ)
Title: Dispenser for metered dosing of animals having piezoelectric elements and method of operation
Inventor: TROMPEN MICK A
IPC: A61M37/00
Filed: 2004-04-01
Abstract: A dispenser (10) for dispensing a liquid onto an animal is disclosed. The dispenser (10) comprises: I) a primary reservoir (12) to hold the liquid, II) a piezoelectric element adjacent or in the primary reservoir, and III) an external capillary means (222) on the exterior of the dispenser. The piezoelectric element has an inlet to receive liquid from the primary reservoir and an outlet for the liquid to exit. The external capillary means is configured to allow the liquid exiting the piezoelectric outlet to collect or pool in or on the external capillary means and eventually roll from the external capillary means onto the animal.
Patent NZ-543500-A (NZ)
Title: A game
Inventor: STOLTEN MARK RANDALL
Filed: 2005-11-09
Abstract: A set of cards for a game for at least two or more players is disclosed. The set of cards comprises a set if criteria cards and a set of point cards with the rules of the game comprising: (i) that a winner is that player or players that obtain(s) any one or more of the following: (a) the most cards, (b) the most points or (c) obtaining a specific card, or specific combination of cards, (ii) that each player holds the criteria related card(s) in either (a) an active state, or (b) a spare state, and (iii) that a player qualifies for obtaining a point card if the player's the active criteria related cards match to the criteria of a the point card. Each criteria card bears an indicia identifying each the criteria card to one of a plurality of criteria related card subsets. Each point card bears an indicia or symbol indicating the criteria card or cards required for obtaining that the point card.
Patent NZ-544285-A (NZ)
Title: Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders
Inventor: HARATS DROR
IPC: A61K31/215
Filed: 2004-05-27
Abstract: Disclosed is a compound of formula I, wherein the substituents are as defined in the specification. The compounds are oxidized lipids which can be used for the manufacture of a composition for treating or preventing an inflammation or inflammatory disease or disorder associated with an endogenous oxidized lipid.
Patent NZ-545835-A (NZ)
Title: Dimethoxy docetaxel acetone solvate and method for the preparation thereof
Inventor: DIDIER ERIC
IPC: A61K31/58
Filed: 2004-09-16
Abstract: Disclosed is an acetone solvate of 4-acetoxy-2alpha-benzoyloxy-5beta,20-epoxy-1-hydroxy-7beta,10beta-dimethoxy-9-oxotax-11-en-13alpha-yl (2R,3S)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenylpropionate, and a process for its preparation, which comprises crystallizing the compound from a mixture of water and of acetone, seeding the solution with a suspension of said product in an acetone/water mixture, treating with water, and drying the product obtained under reduced pressure.
Patent NZ-548500-A (NZ)
Title: An animal model for type II diabetes mellitus and syndrome X and methods and uses thereof
Inventor: KOOPMANS SIETSE JAN
Filed: 2006-07-13
Abstract: Disclosed is a method for generating a type II diabetes mellitus and/or Syndrome X model in pigs, said method comprising partially destructing pancreatic beta-cells in pigs by administration of streptozotocin (STZ) or alloxan, or a functional equivalent or derivative thereof, by slow infusion lasting at least 10 minutes, and selecting from said pigs a pig that comprises a fasting plasma glucose level higher than 6 mmol/L or a pig that comprises an elevated fasting plasma level of a functional equivalent of glucose as compared to a fasting plasma level of said functional equivalent of a healthy pig. Also disclosed is the use of said pig produced by the above method.
Patent NZ-551124-A (NZ)
Title: Dynamic Wrinkle mapping
Inventor: SCHEEPERS FERDI
IPC: G09G5/00
Filed: 2004-05-27
Abstract: A method for dynamically determining a texture map for a desired pose of an object is disclosed. The method comprises retrieving a plurality of base poses for an object; retrieving a plurality of base texture maps associated with the plurality of base poses; receiving a desired pose for the object; determining a plurality of coefficients associated with the plurality of base poses in response to the desired pose and to the plurality of base poses; and determining a desired texture map in response to the plurality of coefficients and to the plurality of base texture maps. A rendering apparatus is also disclosed which comprises a memory configured to store a first plurality of component poses for a three-dimensional object. The memory is also configured to store a first plurality of component two-dimensional images associated with the first plurality of component poses.; The rendering apparatus also comprises a processor coupled to the memory. The processor is configured to; receive a specification of a desired pose for the three-dimensional object; determine a weighted combination of a second plurality of component poses from the first plurality of component poses to approximately form the desired pose; form a desired two-dimensional image from a weighted combination of a second plurality of two-dimensional images from the first plurality of two-dimensional images. The second plurality of two-dimensional images are associated with the second plurality of component poses.
Patent NZ-556628-A (NZ)
Title: Diaza-spiro-[4.4]-nonane derivatives as neurokinin (NK1) antagonists
Inventor: JANSSENS FRANS EDUARD
IPC: A61K31/407
Filed: 2006-03-03
Abstract: Disclosed is a diaza-spiro-[4.4]-nonane derivative according to the general Formula (I), wherein : R2 is Ar2, Ar2-alkyl, di(Ar2)alkyl, Het1 or Het1-alkyl; X is a covalent bond or a bivalent radical of formula -O-, -S- or ûNR3-; Q is O or NR3; each R3 independently from each other, is hydrogen or alkyl; R1 is selected from the group ofAr1, Ar1-alkyl and di(Ar1)-alkyl; m and n are both equal to 1; Z is a covalent bond or a bivalent radical of formula ûCH2- or >C(=O); the spiro moiety has the formula (f6) or (f8) wherein "a" denotes the piperidinyl-moiety and "b" denotes the Alk-Y-Alk-L moiety; T is =O in an alpha-position relative to the N-atom and t is an integer, equal to 0 or 1; each Alk represents, independently from each other, a covalent bond; a bivalent straight or branched, saturated or unsaturated hydrocarbon radical having from 1 to 6 carbon atoms; or a cyclic saturated or unsaturated hydrocarbon radical having from 3 to 6 carbon atoms; each radical optionally substituted on one or more carbon atoms with one or more, phenyl, halo, cyano, hydroxy, formyl and amino radicals; Y is a covalent bond or a bivalent radical of formula -C(=O)-, -SO2- >C=CH-R or >C=N-R, wherein R is H, CN or nitro; L is selected from the group of hydrogen, alkyl, alkenyl, alkyloxy, alkyloxyalkyloxy, alkylcarbonyloxy, alkyloxycarbonyl, mono- and di(alkyl)amino, mono- and di(alkyloxycarbonyl)amino, mono- and di(alkylcarbonyl)amino, mono-and di(Ar3)amino, mono-and di(Ar3alkyl)amino, mono- and di(Het2)amino, mono- and di(Het2alkyl)amino, alkylsulfonyl, norbornyl, adamantyl, tricycloundecyl, Ar3, Ar3-oxy, Ar3carbonyl, Het2, Het-oxy, Her2carbonyl and mono- and di(Het2carbonyl)amino; The remaining substituents are defined herein. Also disclosed is the use of the above compounds for the manufacture of a medicament for treating tachykinin mediated conditions, and also for the treatment and/or prophylaxis of schizophrenia, emesis, anxiety and depression, irritable bowel syndrome (lBS), circadian rhythm disturbances, pre-eclampsia, nociception, pain, in particular visceral and neuropathic pain, pancreatitis, neurogenic inflammation, asthma, chronic obstructive pulmonary disease (COPD) and micturition disorders such as urinary incontinence.
Patent NZ-573698-A (NZ)
Title: Barbituric and thiobarbituric amino acid derivatives as prolyl hydroxylase inhibitors
Inventor: DUFFY KEVIN J
IPC: C07D239/60
Filed: 2007-06-22
Abstract: Disclosed are heteroaromatic N-substitued glycine derivative compounds of formula (I), wherein the substituents are as defined within the specification. Examples of compounds of formula (I) include: N-{ [1-(4-chlorophenyl)-6-hydroxy-4-oxo-3-(phenylmethyl)-2-thioxo-1,2,3,4-tetrahydro-5-pyrimidinyl]carbonyl} glycine; and N-[(1,3-dicyclohexyl-6-hydroxy-2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)carbonyl]glycine. Further disclosed is a pharmaceutical composition comprising a compound of formula (I), and the use of a compound of formula (I) in the manufacture of a medicament for treating anemia, ischemia, and myocardial infarction. Also disclosed is a process for preparing a compound of formula (I).
Patent NZ-573940-A (NZ)
Title: Detection device for a flow of milk in a channel
Inventor: KNOCHE REINHOLD
IPC: A01J5/013
Filed: 2007-06-19
Abstract: A device for detecting a flow of milk is disclosed. The device comprises a channel (2), which has an inlet (3) and an outlet (4). At least two electrically conductive elements (8, 12), which are arranged spaced apart from one another, are provided in the channel (2). At least one element (8) is substantially annular. Furthermore, at least one element (12) is essentially pin-shaped. The channel (2) has at least one chamber (15), which has at least one measuring unit (18) for measuring the conductance of the milk, wherein the chamber (15) has an inlet opening (16), upstream of which a flow element is arranged. This configuration according to the invention of a device for detecting a flow of milk results in a relatively simple design of the device which has relatively high measurement accuracy.
Patent NZ-578306-A (NZ)
Title: Method for producing gamma-carboxylated proteins
Inventor: FENGE CHRISTEL
IPC: A61K38/00
Filed: 2004-10-12
Abstract: Disclosed is a host cell comprising at least one expression vector comprising a nucleic acid molecule encoding a protein requiring gamma-carboxylation and associated expression control sequences comprising a first promoter and a nucleic acid molecule encoding a gamma-glutamyl carboxylase and associated expression control sequences comprising a second promoter, wherein the first promoter is sufficiently stronger than the second promoter so that the protein requiring gamma-carboxylation and the gamma-glutamyl carboxylase are expressed in a ratio of at least 10: 1. The first promoter is human cytomegalovirus (hCMV) immediate-early promoter and the second promoter is SV40 early promoter.
Patent NZ-578382-A (NZ)
Title: Pipe coupler having pre-formed sealable channel for leak detection
Inventor: GOLINVEAUX JAMES E
IPC: F16L55/00
Filed: 2008-01-10
Abstract: Systems and methods for evaluating a piping system for an improperly assembled fluid tight connection. Provided is a preferred joint assembly (100) unable to hold fluid pressure in either one of a dry fit connection and partial seal connection. The joint assembly includes a coupler (300) to identify a leak, the coupler including a tubular wall portion having an outer surface (311), an inner surface (313) defining an interior passageway (315) and a channel (318) in fluid communication with the interior passageway. The channel has a first configuration for carrying a fluid between an interior of the piping system and an exterior of a piping system, and a second configuration to prevent fluid from being carried between the interior and the exterior of the piping system. The channel is further preferably convertible from the first configuration to the second configuration in the presence of a minimum amount of sealant material.
Patent NZ-583007-A (NZ)
Title: Seed treatment compositions and methods
Inventor: ISRAELS RAFEL
IPC: A01N25/00
Filed: 2008-08-14
Abstract: Disclosed is the use of a composition for seed treatment, wherein the composition comprises: active ingredient; polyarylphenol polyalkoxy ether phosphate and/or polyarylphenol polyalkoxy ether sulphate having the formula (I) e.g. pyraclostrobin, wherein in the variables is defined in the specification or an agriculturally acceptable base addition salt thereof; and a copolymer comprising: (i) monomer units of at least one ester of an ethylenically unsaturated carboxylic acid, wherein the carboxylic acid ester has an alkoxylate residue of the general formula (II) (R1)n-X-(CHR2CH2O)w-(CHR3CH2O)x-(CHR4(CH2)yO)z-, e.g. Altox 4913 in which the variable are defined in the specification and (ii) monomer units of at least one additional copolymerizable comonomer.
Patent NZ-583328-A (NZ)
Title: Device for releasably securing two restraint portions with hingedly connected clamping means
Inventor: LUMSDEN BRONWYN
IPC: A01K27/00
Filed: 2008-08-06
Abstract: An elongate securing device is disclosed including a first securing assembly connected to a second securing assembly for releasably securing first and second portions of a restraint. The first securing assembly includes first and second hingedly connected clamping members movable between a secure position and an unsecure position. The first securing assembly further includes ribs extending orthogonal to the elongate body which clamp against the restraint portion in the secure position. The second securing assembly includes a first element connected to the first securing assembly which is hingedly connected to a second element. The second element is movable between unsecure and secure positions to releasably secure the other of the first and second restraint portions.
Patent NZ-586761-A (NZ)
Title: Genetically purified gellan gum
Inventor: CLEARY JOSEPH M
IPC: A23L29/269
Filed: 2005-06-20
Abstract: Provided is a composition comprising gellan gum substantially free of arylsulfatase protein and/or beta- glucuronidase protein and also substantially free from denaturing agent. The composition may be culture broth of Sphingomonas elodea , which has been modified to be arylsulfatase deficient and/or beta-glucuronidase deficient. Further provided are arylsulfatase gene comprising genomic segments of S. elodea and methods of producing the gellan gum.
Patent NZ-586855-A (NZ)
Title: New chromene compounds, a process for their preparation and pharmaceutical compositions containing them
Inventor: DE NANTEUIL GUILLAUME
IPC: C07D493/04
Filed: 2010-07-16
Abstract: Disclosed are compounds of formula (I) e.g. (3aS,9bR)-2-[2-(trans-4-aminocyclohexyl)ethyl]-1,2,3,3a,4,9b-hexahydrochromeno[3,4-c]pyrrole-8-carbonitrile wherein R1 and R2 are defined in the specification, their enantiomers, their diastereoisomers, and also addition salts thereof with a pharmaceutically acceptable acid or base for use in the treatment or prevention of schizophrenia and other psychoses, abuse of drugs, as anxious states and toxicomania, the treatment of bipolar depressive states, impulsive behaviours such as obsessivecompulsive aggressiveness, treatment of Parkinson's disease, memory and other cognitive disorders associated with psychiatric and neurological diseases such as dementias and Alzheimer's disease, adolescents, the treatment of pain, nausea, premature ejaculation and also for renal protection. Also disclosed is a process for the preparation of said compounds characterised in that there is used as starting material bicyclo[2.2.2]oct-5-ene-2-carbonitrile which is subjected to a reductive amination reaction in the presence of a reducing agent, such as sodium triacetoxyborohydride or sodium cyanoborohydride, and an aminocyclohexyl acetalaldehyde compound which is then subjected to a reaction deprotecting the amine function, for example in the presence of trifluoroacetic acid, to yield the desired compound.
Patent NZ-588881-A (NZ)
Title: Inhaler for dispensing a medicament powder
Inventor: SATO TETSUYA
IPC: B01F27/906
Filed: 2009-05-22
Abstract: Disclosed is a powder inhaler which does not require shaking and can be efficiently operated. The powder inhaler is provided with a housing (1) equipped with an inhaling opening; a containing section provided in the housing and containing medicament powder (4); and a medicament conveying section provided in the housing. The medicament conveying section has at least one recess for receiving therein a predetermined amount of the medicament powder, and capable of taking, relative to the containing section, both a receiving position at which the medicament conveying section receives the medicament powder from the containing section and an inhaling position at which a user can inhale the medicament powder from the inhaling opening. A stirring member (7) is provided in the containing section for stirring the contained medicament powder. An operating button (3) is mounted to the housing and capable of moving between an initial position and a pushed-in position. When the operating button reciprocates between the initial position and the pushed-in position, the recess in the medicament conveying member moves from the receiving position to the inhaling position and, at the same time, the stirring member operates.
Patent NZ-590504-A (NZ)
Title: A cane or stick with motorised length adjustable device using a threaded member and matching aperture to set the length of two telscoping body members that are locked in position by a coupling ring
Inventor: EVANS CHAD ARTHUR
IPC: A45B1/00
Filed: 2009-06-16
Abstract: A linearly adjustable device such as a walking stick or cane or crutch, the device comprising a main body including at least two circular tubular body sections aligned along a longitudinal axis, said sections being operatively connected together for linear telescopic movement relative to one another in the axial direction; a threaded acme screw linear actuator operatively mounted within the main body for causing the relative axial movement between the body sections, the linear actuator including a drive and a power transmission mechanism operatively connected to the drive, the transmission mechanism including an elongated threaded member operatively connected to one of the body sections and a cooperating threaded member operatively connected to another of the body sections such that relative rotation between the elongated threaded member and the cooperating threaded member causes relative movement of the body sections; and a coupling ring releasably coupled to one of the body sections, the coupling ring including one or more biased members which cooperate with a longitudinal slot provided in the other body section for restricting relative rotation between the body sections. A battery powered electric motor operated by a variable speed switch moves the threaded member to move the body sections apart or closer between maximum and minimum stops.
Patent NZ-591685-A (NZ)
Title: Improvements in or relating to fertilisers
Inventor: SINCLAIR CLIVE PREBBLE
IPC: C05B15/00
Filed: 2011-03-11
Abstract: Abstract 591685 Disclosed is a method for making mineral fertilizer by a fermentation process at a raised temperature under aerobic conditions in order to partially solubilise the required mineral, wherein the water content of the mineral fertilizer is maintained at a low level of between 2% and 5% by weight. Chelated trace elements, and sulphur may be added. Fermentation occurs more quickly, and is more certainly aerobic. The mineral fertilizer flows freely during distribution Phosphate-rich and lime-rich versions may be mixed without cross-reaction.
Patent NZ-592527-A (NZ)
Title: Process for preparing crystalline form 1 of fluazinam
Inventor: COHEN SHLOMI
IPC: C07D213/61
Filed: 2006-11-23
Abstract: 592527 Disclosed is a process for the preparation of a the most stable crystalline polymorphic form of fluazinam (i.e. polymorphic Form I of 3-chloro-N-(3-chloro-5-trifluoromethyl-2-pyridyl)-?,?,?-trifluoro-2,6-dinitro-p-toluidine / 3-chloro-N-[3-chloro-2,6-dinitro-4-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-2-pyridinamine) exhibiting an X-ray powder diffraction pattern having characteristic peaks expressed in degrees 2? (+/- 0.20 DEGREE ?) at about 8.7, 10, 12.0, 13.7, 14.5, 17.4, 18.5, 19.7, 21.8, 22.9, and 30.2; the process comprising the steps of crystallizing fluazinam from a solvent selected from ethanol, diethyl ether, acetone, isopropanol, toluene, acetonitrile, methylene chloride / dichloromethane and n-hexane; and isolating the resulting crystals.
Patent NZ-599516-A (NZ)
Title: Antibodies binding preferentially human csf1r extracellular domain 4 and their use
Inventor: RIES CAROLA
IPC: A61P35/00
Filed: 2010-12-07
Abstract: Disclosed is an antibody binding to human CSF-IR, characterized in that the antibody binds to human CSF-IR fragment delD4 (SEQ ID NO: 65) and to human CSF-IR Extracellular Domain (SEQ ID NO : 64) with a ratio of 1 :50 or lower.
Patent NZ-615854-A (NZ)
Title: Dose setting mechanism and injection device
Inventor: PLUMPTRE DAVID AUBREY
IPC: A61M5/315
Filed: 2012-03-22
Abstract: Disclosed are dose setting mechanism for a drug delivery device and an injection device. The dose setting mechanism comprises a dose setting member (3); drive member (4) and clutch member (5). The clutch member (5) is located between the dose setting member (3) and the drive member (4). The clutch member (5) is axially movable relative to the dose setting member (3) and the drive member (4). The clutch member (5) is rotationally fixed to the drive member (4) and provides a first clutch for rotationally coupling and decoupling the dose setting member (3) and the drive member (4). A clicker (6) comprising a first component (6’) and a second clicker component (6’’) are axially movable relative to each other for producing tactile and/or audible feedback during relative rotational movement there between. The first clicker component (6’) is axially movable relative to the drive member (4) providing a second clutch member for rotationally coupling and decoupling the drive member (4) and the first clicker component (6’). The first and second clutches are designed and adapted to each other such that at any time during operation either the first clutch rotationally couples the dose setting member (3) and the drive member (4) and/or the second clutch rotationally couples the drive member (4) and the first clicker component (6’).